App aims to keep cancer treatment on track for minority patients

NCT ID NCT05812274

Terminated Symptom relief Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Feb 06, 2026 · Last updated May 21, 2026 · Updated 12 times

Summary

This study tested a mobile app called ApricityCare for minority patients with non-small cell lung cancer who are receiving immunotherapy. The goal was to see if the app helps patients report side effects quickly, reduce treatment delays, and lower the need for hospital visits. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center

New York, New York, 10032, United States
Montefiore Health Center

New York, New York, 10029, United States
Mount Sinai School of Medicine

New York, New York, 10029, United States
NYU Medical Center

New York, New York, 10029, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER